Summit Therapeutics Inc. (SMMT)

Healthcare · Biotechnology · NASDAQ

Summit Therapeutics Inc. (SMMT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $13.66B and a free-cash-flow yield of -2.5%.

Market cap	$13.66B
Trailing P/E	—
FCF yield	-2.5%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SMMT data on Nama Insights →